ABCC2 and cholestasis: Other drugs/metabolites such as estradiol 17β-glucuronide inhibit BSEP only after secretion into the canalicular lumen via MRP2 (trans-inhibition) [51], thus constituting a pivotal mechanism for oral contraceptive-induced cholestasis.